The rate of dropout in studies of oral semaglutide has been significant, approximately 25% in recent trials, reflecting tolerability concerns, mainly due to nausea (source)
Lost 28 lbs "After struggling with weight loss, I discovered Willow and highly recommend it." Chelsea D
Insurance plan ($99/mo) for brand-name access
"Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake." Cell Metabolism , 30(5), 987-996
It promotes fullness and metabolic regulation, outperforming semaglutide in clinical studies for substantial weight loss and enhanced glycemic control
The most common side effects are gastrointestinal, including nausea (12-24% of patients), diarrhea (12-17%), decreased appetite (10-14%), vomiting (6-12%), and constipation (11-17%)